Wed, May 1, 2024
[ 12:00 AM ] - WOPRAI
Tue, February 6, 2024
[ 12:00 AM ] - WOPRAI
Tue, January 23, 2024
[ 12:00 AM ] - WOPRAI
Thu, October 5, 2023
[ 12:00 AM ] - WOPRAI
Fri, August 4, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, August 3, 2023
[ 12:00 AM ] - WOPRAI
Thu, July 20, 2023
[ 12:00 AM ] - WOPRAI
Tue, June 27, 2023
[ 12:00 AM ] - WOPRAI
Wed, May 10, 2023
[ 12:00 AM ] - WOPRAI
Fri, May 5, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, May 2, 2023
[ 12:00 AM ] - WOPRAI
Wed, April 26, 2023
[ 12:00 AM ] - WOPRAI
Wed, April 19, 2023
[ 12:00 AM ] - WOPRAI
Tue, April 18, 2023
[ 12:00 AM ] - WOPRAI
Fri, February 17, 2023
[ 12:00 AM ] - WOPRAI
Thu, February 9, 2023
[ 12:00 AM ] - WOPRAI
Wed, February 8, 2023
[ 12:00 AM ] - WOPRAI
Fri, February 3, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, January 27, 2023
[ 12:00 AM ] - WOPRAI
Thu, January 26, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, January 12, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Christopher Parkinson Maintained (APD) at Strong Buy with Decreased Target to $286 on, May 1st, 2024
Christopher Parkinson of Mizuho, Maintained "Air Products and Chemicals, Inc." (APD) at Strong Buy with Decreased Target from $295 to $286 on, May 1st, 2024.
Christopher has made no other calls on APD in the last 4 months.
There are 5 other peers that have a rating on APD. Out of the 5 peers that are also analyzing APD, 4 agree with Christopher's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Joshua Spector of "UBS" Downgraded from Strong Buy to Hold and Decreased Target to $241 on, Thursday, February 8th, 2024
- Vincent Andrews of "Morgan Stanley" Maintained at Hold with Decreased Target to $240 on, Wednesday, February 7th, 2024
- Michael Harrison of "Seaport Global" Downgraded from Strong Buy to Hold on, Tuesday, February 6th, 2024
- Michael Leithead of "Barclays" Maintained at Hold with Decreased Target to $245 on, Tuesday, February 6th, 2024
This is the rating of the analyst that currently disagrees with Christopher
- Chris Parkinson of "Wolfe Research" Initiated at Buy on, Friday, March 1st, 2024
Contributing Sources